<DOC>
	<DOCNO>NCT02870738</DOCNO>
	<brief_summary>Women interstitial cystitis/bladder pain syndrome ( IC/BPS ) debilitate urinary frequency urgency , chronic pelvic bladder pain perceive related bladder . Although many clinician think IC/BPS symptom result bladder problem , tight pelvic floor muscle cause similar symptom might responsible ICBPS symptom instead bladder . Inadequate assessment problem lead delay treatment often year suffer . This clinical trial test bladder direct therapy ( bladder instillation ) compare course pelvic floor physical therapy ( PFPT ) ass role pelvic floor major contributor pelvic pain void dysfunction adult woman non-ulcerative IC/BPS . Early assessment pelvic floor muscle patient IC/BPS symptom may prevent common delay proper diagnosis allow early , effective treatment .</brief_summary>
	<brief_title>Bladder Directed vs. Pelvic Floor Therapy IC/BPS</brief_title>
	<detailed_description>This prospective randomize trial pelvic floor therapy vs. bladder direct therapy . The study target population consist female , age 18 85 year age clinical diagnosis IC/BPS symptoms chronic urinary frequency , pelvic pain/discomfort , and/or urinary urgency . The approximate number subject enrol study 128 , 64 woman treatment group . Women satisfy eligibility criterion enrol study randomize receive bladder treatment ( instillation medication bladder ) pelvic floor physical therapy . Outcome measure include validated questionnaire , void diary , Global Response Assessment ( GRA ) . The investigator also evaluate change pelvic floor muscle tone discomfort pre post treatment , relationship symptom change . Finally , investigator utilize well-established urine serum biomarkers evaluation pre post treatment determine correlate symptom change .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Cystitis</mesh_term>
	<mesh_term>Cystitis , Interstitial</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<criteria>Female Age 18 85 year History clinical diagnosis IC/BPS ( patient self report ) Using approve method birth control , surgically sterile , nonchild bearing age menstrual period past 12 month Mean urinary frequency least 8 time per 24 hour three day void diary Mean pelvic pain/discomfort score 3 great ( 010 scale ) least one day three day void diary Mean urinary urgency score 2 great ( 05 scale ) three day void diary Self report discomfort pain pelvic region present least six month Must willing start new medication know affect bladder muscle function , remain stable dose medication secondary endpoint . Active urethral ureteral calculus , urethral diverticulum , history pelvic radiation therapy , tuberculous cystitis , bladder cancer , carcinoma situ ( bladder ) , urethral cancer Hunner 's lesion find screen cystoscopy Prior investigational therapeutic bladder instillation IC/BPS symptom DSMO Lactation , pregnancy , refusal medically approved/reliable birth control woman childbearing potential . Pain , frequency , and/or urgency symptom present menses Clinically confirm urinary tract infection time screen Participant unable tolerate insertion one two vaginal examine finger ( e.g . Vulvar allodynia ) Participant prior course PT include internal ( vaginal and/or rectal ) manual therapy connective tissue manipulation physical therapist symptom ( prior treatment therapist biofeedback , electrical stimulation , pelvic floor exercise exclusionary ) Participant opinion investigator relevant neurologic disorder affect bladder and/or neuromuscular function Participant has/reports severe , debilitate urgent concurrent , medical condition Participant potentially significant pelvic pathology abnormality examination prior imaging , include prolapse beyond hymenal ring , pelvic mass , etc. , investigator ' judgment , could cause contribute clinical symptom , require treatment Any condition , investigator 's judgment , may increase risk subject 's welfare Participation investigational trial us study treatment le 6 month date screen visit</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>